ZYGLIP

Tablet, 145mg
RxActive license

Active substance (INN)

fenofibrate

Pharmaceutical form

Pharmaceutical formTablet
Strength145mg
PackagingUkupno 30 tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerAlkaloid AD Skopje, North Macedonia
Therapeutic groupCardiovascular system (C10AB05)
Marketing authorization holderDRUŠTVO "ALKALOID" D.O.O. PODGORICA
Authorization dateDecember 24, 2024

Analogs in Montenegro

3

Other medicines with the same active substance

Source: CInMED register